78 related articles for article (PubMed ID: 26408721)
1. Decreased Expression of PDHE1α Predicts Worse Clinical Outcome in Esophageal Squamous Cell Carcinoma.
Zhong Y; Huang R; Li X; Xu R; Zhou F; Wang J; Fan H; Goscinski M; Zhang M; Wen JG; Nesland JM; Suo Z
Anticancer Res; 2015 Oct; 35(10):5533-8. PubMed ID: 26408721
[TBL] [Abstract][Full Text] [Related]
2. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics.
Uemura N; Nakanishi Y; Kato H; Saito S; Nagino M; Hirohashi S; Kondo T
Int J Cancer; 2009 May; 124(9):2106-15. PubMed ID: 19142970
[TBL] [Abstract][Full Text] [Related]
5. A three-protein signature and clinical outcome in esophageal squamous cell carcinoma.
Cao HH; Zhang SY; Shen JH; Wu ZY; Wu JY; Wang SH; Li EM; Xu LY
Oncotarget; 2015 Mar; 6(7):5435-48. PubMed ID: 25605255
[TBL] [Abstract][Full Text] [Related]
6. Tumor budding and E-cadherin expression are useful predictors of nodal involvement in T1 esophageal squamous cell carcinoma.
Nakagawa Y; Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Shibutani M; Yamazoe S; Kimura K; Nagahara H; Amano R; Ohtani H; Yashiro M; Maeda K; Hirakawa K
Anticancer Res; 2013 Nov; 33(11):5023-9. PubMed ID: 24222146
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evidence of association between ghrelin expression and tumor growth in esophageal carcinoma.
Omoto I; Matsumoto M; Uchikado Y; Kita Y; Sakurai T; Sasaki K; Setoyama T; Okumura H; Owaki T; Ishigami S; Natsugoe S
Anticancer Res; 2014 Jun; 34(6):2727-33. PubMed ID: 24922633
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Sox3 is associated with diminished prognosis in esophageal squamous cell carcinoma.
Li K; Wang RW; Jiang YG; Zou YB; Guo W
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S459-66. PubMed ID: 23238694
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma.
Zhang X; Xu Y; He C; Guo X; Zhang J; He C; Zhang L; Kong M; Chen B; Zhu C
J Surg Oncol; 2015 Jun; 111(7):834-9. PubMed ID: 25919911
[TBL] [Abstract][Full Text] [Related]
10. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
[TBL] [Abstract][Full Text] [Related]
11. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Morita M; Nakao M; Baba H
Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of abnormal expression of Aurora-A in human esophageal squamous cell carcinoma with or without lymph node metastasis].
Shi J; Xue LY; Yin N; Lu J; Fu M; Dong LJ; Shao SJ; Tong T; Zhan QM
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):748-51. PubMed ID: 21163064
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma.
Kim HS; Won KY; Kim GY; Kim SC; Park YK; Kim YW
Pathol Res Pract; 2012 May; 208(5):292-9. PubMed ID: 22464151
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma.
Li Y; Yu H; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
J Surg Oncol; 2011 Nov; 104(6):617-22. PubMed ID: 21744352
[TBL] [Abstract][Full Text] [Related]
15. The impact of tumor cell differentiation on survival of patients with resectable esophageal squamous cell carcinomas.
Hou X; Gu YK; Liu XW; Fu JH; Wang X; Zhang LJ; Luo RZ; Lin P; Yang HX
Ann Surg Oncol; 2015 Mar; 22(3):1008-14. PubMed ID: 25201504
[TBL] [Abstract][Full Text] [Related]
16. Significance of lymph node capsular invasion in esophageal squamous cell carcinoma.
Sakai M; Suzuki S; Sano A; Tanaka N; Inose T; Sohda M; Nakajima M; Miyazaki T; Kuwano H
Ann Surg Oncol; 2012 Jun; 19(6):1911-7. PubMed ID: 22290569
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin 7 is a predictive marker for survival in patients with esophageal squamous cell carcinoma.
Oue N; Noguchi T; Anami K; Kitano S; Sakamoto N; Sentani K; Uraoka N; Aoyagi K; Yoshida T; Sasaki H; Yasui W
Ann Surg Oncol; 2012 Jun; 19(6):1902-10. PubMed ID: 22203179
[TBL] [Abstract][Full Text] [Related]
18. High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma.
Li Y; Wen ZS; Yang HX; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
Ann Surg Oncol; 2011 Nov; 18(12):3370-6. PubMed ID: 21630125
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase II alpha expression in esophageal squamous cell carcinoma.
Ohashi Y; Sasano H; Yamaki H; Shizawa S; Kikuchi A; Shineha R; Akaishi T; Satomi S; Nagura H
Anticancer Res; 1999; 19(3A):1873-80. PubMed ID: 10470130
[TBL] [Abstract][Full Text] [Related]
20. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.
Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T
Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
